Updated
Updated · The Guardian · Nov 2
29 NHS Trusts Dispute Palantir Benefit Claims on £330 Million AI Platform
Updated
Updated · The Guardian · Nov 2

29 NHS Trusts Dispute Palantir Benefit Claims on £330 Million AI Platform

3 articles · Updated · The Guardian · Nov 2

Summary

  • FOI responses from 29 NHS trusts said Palantir’s federated data platform was not live, not operationally used or not being rolled out, despite NHS England listing them as “realising benefits.”
  • The mismatch centers on NHS England’s broader definition of use: it says nearly 140 trusts have reported benefits, including some using only back-office data submission or cost-calculation functions rather than patient-care apps.
  • The disclosure adds pressure on Palantir’s 2024 NHS contract, with Commons committee chair Chi Onwurah urging ministers to trigger a 2027 break clause and reopen bidding to a UK-based supplier.
  • The Office for Statistics Regulation said it will take the new claims forward under its casework function, after earlier scrutiny of NHS England’s assertion that FDP-linked trusts delivered 117,539 extra operations without proven causation.
  • Palantir rejects calls to scrap the deal, saying its software improved operations, discharge delays and cancer-target performance, even as critics question whether the project’s reported benefits match reality.

Insights

Why is a £330m NHS data system hailed as a success while dozens of hospitals secretly refuse to use it?
With a crucial 2027 break clause approaching, will the government abandon its costly data deal or force hospitals to comply?
Could rising public fear and mass data opt-outs ultimately destroy the effectiveness of the controversial new health tech platform?